mafosfamide has been researched along with mesna in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farquhar, D; Wang, YQ | 1 |
| Brock, N | 1 |
| Schwieder, G; Wagner, T; Zink, M | 1 |
| Hilgard, P; Pohl, J | 1 |
1 review(s) available for mafosfamide and mesna
| Article | Year |
|---|---|
Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture.
Topics: Cyclophosphamide; Humans; Ifosfamide; Mesna; Organ Specificity | 1989 |
3 other study(ies) available for mafosfamide and mesna
| Article | Year |
|---|---|
Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
Topics: Animals; Antineoplastic Agents; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Survival; Drug Screening Assays, Antitumor; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Phosphoramide Mustards; Prodrugs; Structure-Activity Relationship | 1991 |
Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.
Topics: Animals; Cyclophosphamide; Cysteine; Drug Interactions; Female; Leukemia L1210; Mercaptoethanol; Mesna; Metabolic Clearance Rate; Mice; Platelet Count; Sulfhydryl Compounds | 1987 |
Cause and prevention of mafosfamide-induced venous pain.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cyclophosphamide; Mesna; Pain; Rats; Veins | 1986 |